In 2024, the U.S. list prices for a one-month supply for most GLP-1s are stable or increasing, but after payer negotiations and rebates, net prices for many GLP-1s have decreased since 2022. Net prices for GLP-1s are between 24% and 73% lower than list prices, indicating that most insurers are paying less than the manufacturer’s list price.
“The future path of prices of drugs in this class will be affected by the number of approved conditions for each drug, whether any of the drugs are selected for price negotiation by Medicare, and the number of new drugs that become available, including potential future new entrants into the market,” HHS said.
Net price change since launch:
Mounjaro:
2022: $122.92
2024: $291.67
Increased 137% since 2022
Wegovy:
2021: $534.00
2024: $649.42
Increased 22% since 2021
Saxenda:
2017: $842.17
2024: $703.08
Decreased 17% since 2017
Rybelsus:
2020: $376.75
2024: $296.33
Decreased 21% since 2020
Ozempic:
2018: $531.08
2024: $290.08
Decreased 45% since 2018
Victoza:
2017: $541.83
2024: $282.75
Decreased 48% since 2017
List price change since launch:
Ozempic:
2018: $676.00
2024: $968.52
Increased 43% since 2018
Rybelsus:
2020: $772.43
2024: $968.52
Increased 25% since 2020
Saxenda:
2017: $1,154.25
2024: $1,349.00
Increased 17% since 2017
Mounjaro:
2022: $974.32
2024: $1,069.08
Increased 10% since 2022
Victoza:
2017: $249.21
2024: $271.76
Increased 9% since 2017
Wegovy:
2021: $1,349.08
2024: $1,349.08
No change since 2021
Zepbound:
2023: $1,059.88
2024: $1,059.88
No change since 2023
Interested in sharing your thoughts? Take this quick survey about how your system is approaching GLP-1 medications here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
